Maxime Bréban

10.3k total citations · 1 hit paper
172 papers, 5.5k citations indexed

About

Maxime Bréban is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Maxime Bréban has authored 172 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Rheumatology, 75 papers in Immunology and 42 papers in Hematology. Recurrent topics in Maxime Bréban's work include Spondyloarthritis Studies and Treatments (106 papers), Rheumatoid Arthritis Research and Therapies (66 papers) and Psoriasis: Treatment and Pathogenesis (52 papers). Maxime Bréban is often cited by papers focused on Spondyloarthritis Studies and Treatments (106 papers), Rheumatoid Arthritis Research and Therapies (66 papers) and Psoriasis: Treatment and Pathogenesis (52 papers). Maxime Bréban collaborates with scholars based in France, United States and Germany. Maxime Bréban's co-authors include Roula Said‐Nahal, Maria Antonietta D’Agostino, Cécile Hacquard‐Bouder, Gilles Chiocchia, Maxime Dougados, Robert E. Hammer, Joel D. Taurog, Félicie Costantino, Jean‐Louis Brasseur and James A. Richardson and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Infection and Immunity.

In The Last Decade

Maxime Bréban

158 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

2009 460 citations Florence Tubach, Dominique Salmon et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Maxime Bréban

Since Specialization

Citations

This map shows the geographic impact of Maxime Bréban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Bréban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Bréban more than expected).

Fields of papers citing papers by Maxime Bréban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Bréban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Bréban. The network helps show where Maxime Bréban may publish in the future.

Co-authorship network of co-authors of Maxime Bréban

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Bréban. A scholar is included among the top collaborators of Maxime Bréban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Bréban. Maxime Bréban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Family studies: A useful tool to better understand spondyloarthritis 2023 ·Joint Bone Spine ·Félicie Costantino, Maxime Bréban	1
2	Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis 2023 ·Lara D. Veeken ·(unknown), Hélène Gouze, Tania Gudu, (unknown), (unknown), Félicie Costantino, (unknown), Maxime Bréban, E. Mahé, Maria Antonietta D’Agostino	0
3	STAT1 deficiency underlies a proinflammatory imprint of naive CD4+ T cells in spondyloarthritis 2023 ·Frontiers in Immunology ·(unknown), Frédéric Crémazy, (unknown), (unknown), Roula Said‐Nahal, (unknown), Félicie Costantino, (unknown), (unknown), Henri‐Jean Garchon, Simon Glatigny, Luiza M. Araujo, Maxime Bréban	4
4	Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events 2022 ·Arthritis Research & Therapy ·Hélène Gouze, Philippe Aegerter, Roula Said‐Nahal, Marie Zins, Marcel Goldberg, Guillaume Morelle, Georg Schett, Maxime Bréban, (unknown)	6
5	Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations 2021 ·Lara D. Veeken ·Félicie Costantino, Philippe Aegerter, Georg Schett, Ann‐Sophie De Craemer, Anna Moltó, Filip Van den Bosch, Dirk Elewaut, Maxime Bréban, Maria Antonietta D’Agostino	8
6	Effects of a low-dose IL-2 treatment in HLA-B27 transgenic rat model of spondyloarthritis 2021 ·Arthritis Research & Therapy ·Luiza M. Araujo, (unknown), Ingrid Fert, (unknown), Gilles Chiocchia, Maxime Bréban	7
7	COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence 2020 ·Joint Bone Spine ·Félicie Costantino, (unknown), (unknown), Ariane Leboime, (unknown), (unknown), Maxime Bréban, Maria Antonietta D’Agostino	33
8	HLA–B27 Subtypes Predisposing to Ankylosing Spondylitis Accumulate in an Endoplasmic Reticulum–Derived Compartment Apart From the Peptide‐Loading Complex 2020 ·Arthritis & Rheumatology ·(unknown), (unknown), (unknown), (unknown), Gilles Chiocchia, Maxime Bréban, (unknown)	14
9	HLA-B27 alters BMP/TGFβ signalling in Drosophila, revealing putative pathogenic mechanism for spondyloarthritis 2019 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), (unknown), Luiza M. Araujo, Simon Glatigny, (unknown), (unknown), Gilles Chiocchia, Isabelle Guénal, Sébastien Gaumer, Maxime Bréban	23
10	Abrupt and unexpected stressful life events are followed with increased disease activity in spondyloarthritis: A two years web-based cohort study 2018 ·Joint Bone Spine ·(unknown), Pierre‐Yves Boëlle, Clément Turbelin, Félicie Costantino, Solen Kernéis, (unknown), Maxime Bréban, Thomas Hanslik	6
11	Prevalence, Comorbidities and Burden of Severe Spondyloarthritis In France: Analysis of A National Public Health Insurance Database In 2012 In France 2015 ·Value in Health ·Pascal Claudepierre, Maxime Bréban, (unknown), Jean-Michel Joubert, (unknown), J. Gourmelen, Francis Fagnani	1
12	Tocilizumab in refractory adult Still's disease 2010 ·Arthritis Care & Research ·Xavier Puéchal, M. Debandt, Jean‐Marie Berthelot, Maxime Bréban, Jean‐Jacques Dubost, Olivier Fain, Jean‐Emmanuel Kahn, L. Lequen, M. Longy‐Boursier, Aleth Perdriger, Thierry Schaeverbeke, Éric Toussirot, Jean Sibilia, (unknown)	113
13	Comprehensive Linkage and Association Analyses Identify Haplotype, Near to the TNFSF15 Gene, Significantly Associated with Spondyloarthritis 2009 ·PLoS Genetics ·Elena Zinovieva, Catherine Bourgain, Amir Kadi, Franck Letourneur, Brigitte Izac, Roula Said‐Nahal, Nicolas Lebrun, Nicolas Cagnard, (unknown), Sébastien Jacques, Corinne Miceli‐Richard, Henri‐Jean Garchon, Simon Heath, Céline Charon, Delphine Bacq, Anne Boland, Diana Zélénika, Gilles Chiocchia, Maxime Bréban	46
14	Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry breakdown → 2009 ·Arthritis & Rheumatism ·Florence Tubach, Dominique Salmon, Philippe Ravaud, Yannick Allanore, Philippe Goupille, Maxime Bréban, (unknown), Sophie Pouplin, Alessandra Sacchi, (unknown), Stéphane Bretagne, D Émilie, Marc Lémann, (unknown), Xavier Mariette	460
15	Quelles sont les modifications gastriques induites par l'infection aiguë et chronique par Helicobacter pylori ? 2008 ·Gastroentérologie Clinique et Biologique ·Dominique Lamarque, Jeanne Tran Van Nhieu, Maxime Bréban	4
16	Combined analysis of three whole genome linkage scans for Ankylosing Spondylitis 2007 ·Lara D. Veeken ·Kim W. Carter, Anna Pluzhnikov, Andrew E. Timms, Corinne Miceli‐Richard, Catherine Bourgain, B P Wordsworth, Hélène Jean‐Pierre, Nancy J. Cox, Lyle J. Palmer, Maxime Bréban, John D. Reveille, Matthew A. Brown	50
17	Characterization and Functional Consequences of Underexpression of Clusterin in Rheumatoid Arthritis 2006 ·The Journal of Immunology ·Valérie Devauchelle, (unknown), Gonzague de Pinieux, Stéphane Germain, Léa Tourneur, Sylvie Mistou, Florence Margottin-Goguet, Philippe Anract, Henri Migаud, D. Le Nen, Thierry Lequerré, Alain Saraux, Maxime Dougados, Maxime Bréban, Catherine Fournier, Gilles Chiocchia	69
18	HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors 2004 ·The Journal of Immunology ·Simon Kollnberger, (unknown), (unknown), Cécile Hacquard‐Bouder, Hiromi Kubagawa, Helen C. Bodmer, Maxime Bréban, Andrew J. McMichael, Paul Bowness	103
19	Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience 2002 ·Annals of the Rheumatic Diseases ·Jürgen Braun, Joachim Sieper, Maxime Bréban, Eduardo Collantes‐Estévez, John Davis, Robert D. Inman, Helena Marzo‐Ortega, Herman Mielants	46
20	The familial form of spondylarthropathy: A clinical study of 115 multiplex families 2000 ·Arthritis & Rheumatism ·Roula Said‐Nahal, Corinne Miceli‐Richard, Jean‐Marie Berthelot, (unknown), (unknown), (unknown), Alain Saraux, Aleth Perdriger, Sandrine Guis, Pascal Claudepierre, Jean Sibilia, B Amor, M. Dougados, Maxime Bréban	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact